Thompson Street Capital Partners V, L.P. sells Vetio Animal Health to Swedencare AB
June 30, 2021
On July 1, 2021, Thompson Street Capital Partners V, L.P. (“TSCP”) completed its sale of Vetio Animal Health (“Vetio”) to Swedencare AB.
Vetio is a contract development and manufacturing organization (CDMO) that specializes in complex drug product formulation and manufacturing of veterinary pharmaceutical, supplement, and dermatology products. With offices in St. Louis, Missouri and development and manufacturing in Jupiter, Florida and Montreal, Quebec, Vetio is one of the largest CDMOs dedicated to animal health in North America.
TSCP is a St. Louis-based private equity firm focused on investing in founder-led middle market businesses in the life sciences and healthcare, software and technology and business and consumer services and products sectors. Founded in 2000, the firm has acquired more than 150 companies and has managed more than $2.6 billion in equity.
Swedencare AB, a listed company on NASDAQ First North Growth Market, specializes in pet healthcare and produces, markets and sells premium products in the global and fast-growing market. Swedencare’s headquarters is in Malmö, Sweden with subsidiaries located in seven countries and products sold in approximately fifty markets.
McCarthy Tétrault acted as Canadian counsel to TSCP with a team lead by Patrick Shea and that included Michel Ranger (Tax), Alexandre Saulnier-Marceau (M&A), Lisa Melanson and Véronique Wattiez Larose (IP and Regulatory) and Caroline Bernier (Employment).